10.62

1.43% 0.15

After Hours: 10.52 -0.10 -0.94%

Brainsway Ltd Adr (BWAY)

Overview News Price History Discussions Forecast

Brainsway Ltd Adr stock is traded at $10.62, with a volume of 21,777. It is up +1.43% in the last 24 hours and up +15.18% over the past month. BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Previous Close:

$10.47

Open:

$10.58

24h Volume:

21,777

Relative Volume:

0.33

Market Cap:

$199.83M

Revenue:

$38.63M

Net Income/Loss:

$1.50M

P/E Ratio:

112.62

EPS:

0.0943

Net Cash Flow:

$5.97M

1W Performance:

-2.84%

1M Performance:

+15.18%

6M Performance:

+40.95%

1Y Performance:

+71.84%

1-Day Range:

$10.51

$10.77

1-Week Range:

$10.24

$11.19

52-Week Range:

$4.61

$11.25

Brainsway Ltd Adr Stock (BWAY) Company Profile

Name

Brainsway Ltd Adr

Sector

Healthcare (1174)

Industry

Medical Devices (154)

Phone

Address

Employee

106

Twitter

@BrainsWay

Next Earnings Date

2024-11-13

Latest SEC Filings

BWAY's Discussions on Twitter

Compare BWAY with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BWAY Brainsway Ltd Adr	10.62	199.83M	38.63M	1.50M	5.97M	0.0943
ABT Abbott Laboratories	128.81	223.42B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	103.04	151.86B	15.91B	1.79B	1.89B	1.21
SYK Stryker Corp	390.43	148.84B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	91.99	117.96B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	73.22	43.19B	6.60B	4.16B	490.10M	6.93

Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-16-23	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-03-22	Initiated	Loop Capital	Buy
Jul-19-21	Initiated	H.C. Wainwright	Buy
Apr-20-21	Initiated	Northland Capital	Outperform
May-13-19	Initiated	Cantor Fitzgerald	Overweight
May-13-19	Initiated	Ladenburg Thalmann	Buy
May-13-19	Initiated	Oppenheimer	Outperform
May-13-19	Initiated	Raymond James	Outperform

View All

Brainsway Ltd Adr Stock (BWAY) Latest News

Jan 28, 2025

Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Jan 28, 2025

Jan 23, 2025

Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last? - MSN

Jan 23, 2025

Jan 22, 2025

Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Jan 22, 2025

Jan 16, 2025

Wall Street Analysts Think Brainsway (BWAY) Could Surge 38.83%: Read This Before Placing a Bet - MSN

Jan 16, 2025

New Strong Buy Stocks for January 14th - MSN

Jan 16, 2025

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why - Yahoo Finance

Jan 16, 2025

Jan 15, 2025

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy - GlobeNewswire Inc.

Nov 20, 2024

Nov 07, 2024

Brainsway stock soars to 52-week high, hits $10.75 - Investing.com

Nov 07, 2024

Oct 31, 2024

Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Oct 31, 2024

Oct 29, 2024

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024 - Yahoo Finance

Oct 29, 2024

Oct 24, 2024